What was the impact of selling Abbott shares on the portfolio?

The sale of Abbott Laboratories shares impacted Elfun Trusts' portfolio by approximately -1.97%.

Did the fund state a reason for selling Abbott shares?

The N-PORT filing did not specify a reason for the sale of Abbott Laboratories shares.

What other companies might be in Elfun Trusts' portfolio?

According to the filing, the portfolio also includes investments in NVIDIA (NVDA) and GE Aerospace (GE) among technology and industrials sectors.

Elfun Trusts Exits Abbott Laboratories, Portfolio Impact -1.97%

A Q1 2026 N-PORT filing reveals that Elfun Trusts completely exited its position in Abbott Laboratories, resulting in a -1.97% impact on the portfolio.

June 11, 2026

2 min read

Source: GuruFocus.com

Key Numbers

portfolio impact

-1.97%

A recent N-PORT filing with the SEC for the first quarter of 2026 reveals that Elfun Trusts (Trades, Portfolio) has completely exited its position in Abbott Laboratories (ABT). The move negatively impacted the fund's portfolio by approximately -1.97%.

Details of the Move

According to the Q1 2026 N-PORT filing, Elfun Trusts liquidated all its holdings in Abbott Laboratories. The filing did not specify a reason for the decision, but it indicates a shift in the fund's investment strategy during that period.

Context

This move comes at a time when healthcare stocks are experiencing volatility due to regulatory changes and increased competition. Abbott Laboratories faces pressure in some of its segments, but it still maintains a strong market position.

What It Means for Investors

Elfun Trusts' decision to exit ABT may signal a reassessment of the healthcare sector, but it does not necessarily reflect a negative view of the company itself. Investors are encouraged to monitor other fund moves and analyst reports for a broader perspective.

Frequently Asked Questions

Elfun Trusts is an investment fund that manages a diversified portfolio of stocks and files periodic disclosures with the SEC.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.